文献速递头颈甲状腺与浅表US

基于甲状腺乳头状癌术前多模态超声的列线图预测中央区淋巴结转移

Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis.
PubMed 文献 · Eur Radiol · 2022-02-28

该回顾性研究纳入822例甲状腺乳头状癌患者,构建基于术前临床与多模态超声特征的甲状腺肿瘤超声模型(TTUM)及甲状腺肿瘤与颈部淋巴结超声模型(TTCLNUM)列线图预测中央区淋巴结转移。TTCLNUM在训练集和测试集的AUC分别为0.806和0.804,校准与决策曲线显示其准确性及临床实用性更高,尤其对不同肿瘤大小患者的CLNM风险预测表现更好。

要点

  • TTCLNUM列线图在训练集和测试集的AUC分别为0.806和0.804,校准与决策曲线显示临床实用性更高。
  • 当超声肿瘤大小≤8.45 mm时,训练集和测试集的AUC分别为0.746和0.719,特异度分别为0.942和0.905。
  • 当超声肿瘤大小>8.45 mm时,训练集和测试集的AUC分别为0.737和0.824,敏感度分别为0.905和0.880。

核心结论

  • TTCLNUM列线图预测性能更优,尤其对不同肿瘤大小的PTC患者CLNM风险,可作为为主动监测和治疗决策提供有价值信息的临床工具。

研究设计与样本

  • 回顾性研究,纳入822例甲状腺乳头状癌患者,基于术前临床和多模态超声特征构建TTUM和TTCLNUM列线图,以AUC评价模型性能,并用校准曲线和决策曲线评估准确性和临床实用性。

关键影像表现/征象

  • TTUM训练集和测试集的AUC分别为0.786和0.789,偏倚校正AUC分别为0.786和0.831。
  • TTCLNUM训练集和测试集的AUC分别为0.806和0.804,偏倚校正AUC分别为0.807和0.827。
  • TTCLNUM列线图的校准曲线和决策曲线显示出更高的准确性和临床实用性。

诊断标准与关键数值

  • 超声肿瘤大小≤8.45 mm时,训练集AUC为0.746、特异度为0.942,测试集AUC为0.719、特异度为0.905。
  • 超声肿瘤大小>8.45 mm时,训练集AUC为0.737、敏感度为0.905,测试集AUC为0.824、敏感度为0.880。

临床应用与阅片要点

  • 术前临床和多模态超声特征可直接用于构建准确且易用的列线图预测中央区淋巴结转移。
  • 该术前无创且直观的预测方法可提高中央区淋巴结转移风险评估的准确性,并指导符合个性化治疗趋势的临床治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To establish a nomogram for predicting central lymph node metastasis (CLNM) based on the preoperative clinical and multimodal ultrasound (US) features of papillary thyroid carcinoma (PTC) and cervical LNs.

METHODS: Overall, 822 patients with PTC were included in this retrospective study. A thyroid tumor ultrasound model (TTUM) and thyroid tumor and cervical LN ultrasound model (TTCLNUM) were constructed as nomograms to predict the CLNM risk. Areas under the curve (AUCs) evaluated model performance. Calibration and decision curves were applied to assess the accuracy and clinical utility.

RESULTS: For the TTUM training and test sets, the AUCs were 0.786 and 0.789 and bias-corrected AUCs were 0.786 and 0.831, respectively. For the TTCLNUM training and test sets, the AUCs were 0.806 and 0.804 and bias-corrected AUCs were 0.807 and 0.827, respectively. Calibration and decision curves for the TTCLNUM nomogram exhibited higher accuracy and clinical practicability. The AUCs were 0.746 and 0.719 and specificities were 0.942 and 0.905 for the training and test sets, respectively, when the US tumor size was ≤ 8.45 mm, while the AUCs were 0.737 and 0.824 and sensitivity were 0.905 and 0.880, respectively, when the US tumor size was > 8.45 mm.

CONCLUSION: The TTCLNUM nomogram exhibited better predictive performance, especially for the CLNM risk of different PTC tumor sizes. Thus, it serves as a useful clinical tool to supply valuable information for active surveillance and treatment decisions.

KEY POINTS: • Our preoperative noninvasive and intuitive prediction method can improve the accuracy of central lymph node metastasis (CLNM) risk assessment and guide clinical treatment in line with current trends toward personalized treatments. • Preoperative clinical and multimodal ultrasound features of primary papillary thyroid carcinoma (PTC) tumors and cervical LNs were directly used to build an accurate and easy-to-use nomogram for predicting CLNM. • The thyroid tumor and cervical lymph node ultrasound model exhibited better performance for predicting the CLNM of different PTC tumor sizes. It may serve as a useful clinical tool to provide valuable information for active surveillance and treatment decisions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Dai, Liu, Tao, et al. Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis. Eur Radiol. 2022. PMID: 35226156. doi:10.1007/s00330-022-08565-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。